Back
Eliem Therapeutics Stock Predictions
Sell
45
ELYM
Eliem Therapeutics
Last Price:
8.17
Seasonality Move:
-25.18%
7 Day Trial
ALL ACCESS PASS
$
7
Eliem Therapeutics Stock Forecast
- Over the next 52 weeks, Eliem Therapeutics has on average historically risen by 67.8% based on the past 2 years of stock performance.
- Eliem Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Eliem Therapeutics Stock Undervalued?
The current Eliem Therapeutics [ELYM] share price is $8.25. The Score for ELYM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - ELYM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Eliem Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Eliem Therapeutics has on average historically risen by 67.8% based on the past 2 years of stock performance.
Eliem Therapeutics Stock Rating
Sell
45
Eliem Therapeutics (ELYM)
is a Sell
Is Eliem Therapeutics overpriced?
- Eliem Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Eliem Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
eliemtx.com
52-Week Data
52-Week High:
11.55
52-Week Low:
2.34
Prediction Charts
Market Cap:
240M
Price in USD:
8.25
Volume:
318.65K
Beta:
-0.37
Technical Analysis
SMA50:
4.75
SMA100:
3.75
SMA200:
3.18
52-Wk Change:
191.52%
Stock Predictions
-
Is Eliem Therapeutics stock public?
Yes, Eliem Therapeutics is a publicly traded company. -
What is the Eliem Therapeutics stock quote today?
The Eliem Therapeutics stock price is 8.25 USD today. -
How to buy Eliem Therapeutics stock online?
You can buy Eliem Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 5.02 | 7.10 | 7.80 | 5.02 |
| May-1 | 6.75 | 7.65 | 7.73 | 6.66 |
| May-2 | 7.75 | 8.34 | 8.75 | 7.50 |
| May-3 | 8.40 | 10.16 | 11.55 | 8.40 |
| May-6 | 10.00 | 8.72 | 10.00 | 8.42 |
| May-7 | 8.61 | 10.25 | 10.34 | 8.44 |
| May-8 | 10.30 | 9.32 | 10.86 | 9.27 |
| May-9 | 9.38 | 8.98 | 10.23 | 8.84 |
| May-10 | 9.18 | 8.46 | 9.56 | 8.33 |
| May-13 | 8.22 | 8.41 | 9.19 | 8.22 |
| May-14 | 8.45 | 8.19 | 8.81 | 8.02 |
| May-15 | 8.49 | 7.99 | 8.50 | 7.86 |
| May-16 | 7.87 | 8.18 | 8.99 | 7.67 |
| May-17 | 8.06 | 8.25 | 8.61 | 7.76 |
Eliem Therapeutics Earnings
Eliem Therapeutics Earnings Report: Per Share Eliem Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Eliem Therapeutics Forecast Revenue Growth
Eliem Therapeutics Stock Analysis: Historical quarterly revenues per share for Eliem Therapeutics and historical quarterly revenue growth:
* Eliem Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.